Dexetimide as an Intervention: 626 Clinical Trials, Page 62 of 63

Hide Studies Not Open or Pending


YouScript IMPACT Registry

Condition(s):Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 VariantLast Updated:March 1, 2017Completed


Drug-induced Repolarization ECG Changes

Condition(s):Long QT Syndrome; ADHD; Depression; Death; Death, Sudden, Cardiac; Romano-Ward Syndrome; Pathologic Processes; Heart Arrest; Electrocardiogram: Electrical Alternans; Heart Diseases; Cardiovascular Diseases; Death, Sudden; Arrhythmias, Cardiac; Heart Defects, Congenital; Cardiovascular Abnormalities; Congenital Abnormalities; Genetic Disease; Genetic Syndrome; Qt Interval, Variation in; Psychiatric DisorderLast Updated:January 3, 2019Active, not recruiting

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.